Changes to US patent regulations may have implications for Australian patent holders.

Starpharma, Atcor, Bionomics, Circadian, CSL, Cochlear, Mesoblast, Pharmaxis [ + ]

Scientisits from all branches of science are encouraged to nominate for the 2009 NSW Scientist of the Year Awards.

Clinical milestone achieved in cystic fibrosis Phase III trial [ + ]

Pharmaxis, Mesoblast, CathRx, Fluorotechnics, Sonic, Avita, Biota [ + ]

Groundbreaking CSIRO research into how the deadly Hendra virus spreads promises to save the lives of both horses and humans in the future.

Concrete proof that Australia can clean up highly contaminated sites thoroughly, safely and economically is emerging from a new national program.

Pharmaxis, Cochlear, CSL, HeartWare, Sirtex, Progen [ + ]

Team Bufo may have found cane toad’s Achilles heel – meat ants [ + ]

Normal animals have one mitochondrial chromosome, but blood-sucking lice have 18 [ + ]

Progen, Cytopia, Avexa, Acrux, Biota, Cellestis [ + ]

Mesoblast raises $10 million from new and existing investors [ + ]

ChemGenex’ lead candidate kills cancer stem cells in animal model [ + ]

Viralytics granted patent in US for oncolytic echoviruses [ + ]

TGR BioSciences CSO Michael Crouch wins Advancing BioBusiness Award [ + ]